S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

NCT00897091 · clinicaltrials.gov ↗

COMPLETED

Status

750

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

GENETIC: comparative genomic hybridization
GENETIC: microarray analysis
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: diagnostic laboratory biomarker analysis

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]